ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1967

Advanced Imaging in the Evaluation of Lupus Arthritis: A Systematic Literature Review and Meta-Analysis

Wei Tang1, Leila Khalili2, Robert Clancy2, Laura Geraldino3, Yevgeniya Gartshteyn4, Kathleen Alvarez2, Mandana Nikpour5 and Anca Askanase2, 1Westchester Medical Center, Valhalla, 2Columbia University Medical Center, New York, NY, 3Division of Rheumatology, Department of Medicine, Columbia University, New York, NY, 4Columbia University Irving School of Medicine, New York, NY, 5The University of Sydney, Melbourne, Victoria, Australia

Meeting: ACR Convergence 2024

Keywords: Imaging, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Joint involvement (swelling, tenderness, deformity and incapacitating inflammatory arthritis) are present in 95% of SLE patients; 70-80% of lupus patients in clinical trials have active joint manifestations. Arthritis is a main cause of work-related disability. The objective of this study was to review the evidence on the application of musculoskeletal (MSK) ultrasound (US) and magnetic resonance imaging (MRI) in SLE patients with hand and wrist arthritis and to provide combined results data from these studies.

Methods: Separate PICOs structured literature searches without language restriction were conducted for US and MRI using PubMed, EMBASE and the Cochrane Library. The search for US was restricted to Jan 1, 2019 – Mar 31, 2024, as the previous systematic reviews included data until Dec 31, 2018. The searches for MRI were done without date restriction until March 31, 2024. The literature was reviewed according to PRISMA guidelines by 2 authors. The inclusion criteria were original research, >18 years old, classified SLE, >/=1patient, and inclusion of hands and wrists. The inter-reader agreement between the 2 authors for selection of the studies was 1.0. Following consensus, full text of the studies that met eligibility were acquired and assessed for the final determination of inclusion. The PRISMA flowchart was created. The quality assessment of studies was based on the QUADAS-2 instrument.

Results: Of 502 articles for US, 16 were included, of 2101 articles for MRI, 8 were included. Data on the use of MSK US and MRI were evaluated separately. For US, we assessed the definitions and scoring of the reported abnormalities, a summary of these data is shown in table 1. 9 US studies investigated the association between arthritis/arthralgia and US synovitis (Fig 1a.), the pooled odds ratio (OR) for the association was 7.11 (95% CI, 2.88 to 17.53). When the analysis was restricted to physician confirmed arthritis (Fig 1b.), the OR decreased to 5.28 (1.79, 15.55). 5 studies examined the association between arthritis/arthralgia and US tenosynovitis (Figure 1c); OR was 5.93 (95% CI 1.99, 17.72). For MRI, table 1 summarizes the main abnormalities, and table 2 provides further details. Unfortunately, we were unable to investigate the association between arthritis/arthralgia and the presence of MRI synovitis, tenosynovitis, or erosions because of the scoring heterogeneity of data reported.

Conclusion: The current systematic literature review examined available information on the use of advanced imaging modalities in the evaluation of SLE hand and wrist arthritis. These data support the use of US and MRI in SLE patients with symptomatic hand arthritis and arthralgia and to detect both symptomatic and asymptomatic MSK involvement as these have clinical and therapeutic implications. There is an urgent need for more precise evolutions of arthritis in clinical care and clinical trials as subjective joint evaluations impact routine care and the outcomes of clinical trials. Further investigation is needed to fully understand the clinical relevance of the newly defined clinical and imaging phenotypes, and their response to treatment.

Supporting image 1

Table 1. Described Abnormalities

Supporting image 2

Figure 1. 1A. Association between ultrasound synovitis and presence of arthritis; 1B. Association between ultrasound synovitis and presence of arthritis confirmed on joint examination

Supporting image 3

Table 2. Definition and Scoring System of MRI Abnormalities


Disclosures: W. Tang: None; L. Khalili: None; R. Clancy: None; L. Geraldino: Aurinia, 1, 2, Bristol Myers Squibb, 1, 2; Y. Gartshteyn: None; K. Alvarez: None; M. Nikpour: AstraZeneca, 2, 5, 6, Boehringer-Ingelheim, 2, 5, 6, Bristol-Myers Squibb(BMS), 5, GlaxoSmithKlein(GSK), 6, Janssen, 2, 5, 6; A. Askanase: AbbVie/Abbott, 2, Amgen, 2, AstraZeneca, 2, Aurinia, 2, Bristol-Myers Squibb(BMS), 2, Cabaletta, 2, Celgene, 2, Eli Lilly, 2, Genentech, 2, GlaxoSmithKline (GSK), 2, Idorsia, 2, Janssen, 2, Mallinckrodt, 2, NKARTA, 2, Pfizer, 2, Sana, 2, Sanofi, 2, UCB, 2.

To cite this abstract in AMA style:

Tang W, Khalili L, Clancy R, Geraldino L, Gartshteyn Y, Alvarez K, Nikpour M, Askanase A. Advanced Imaging in the Evaluation of Lupus Arthritis: A Systematic Literature Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/advanced-imaging-in-the-evaluation-of-lupus-arthritis-a-systematic-literature-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/advanced-imaging-in-the-evaluation-of-lupus-arthritis-a-systematic-literature-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology